Sangamo Therapeutics Inc. [NASDAQ:SGMO] is seeing significant action in the Healthcare space. SGMO stock has price per sales of 12.52 and price per cash flow of 21.86. The company is also booking -0.83 earnings per share.
The tape is active for Sangamo Therapeutics Inc. [SGMO] and the current price target sits at $20.25.
To add more color to this price target, SGMO’s high over the last year is $36.00 and the low is $11.00. Over the last two 52 weeks, the company is trading 34.53%, while the S&P 500 is trading 0.87%.
The Price is right
Holding a Market Cap of $1.39 billion, Sangamo Therapeutics Inc. has seen a trading range over the last year of $4.81-$13.20.
For the last five days, SGMO is up from its last closing price. The average shares trading hands each day is 1.62M, with average 10-day volume coming in at 1.41 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for SGMO. When we apply the Elder Force Index to Sangamo Therapeutics Inc., we are seeing an Elder Force Indicator number of 2055318.46.
The company’s enterprise value has gone from $945.19M to $355.71M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, SGMO made a profit of 59.45 million. Sangamo Therapeutics Inc. also saw quarter revenue growth year over year of 21.29%. In addition, the company has operating cash flow of $81.41 million.
Looking at popular technical indicators, the company’s 5-day moving average is 10.08 compared to the 50-day moving average of 10.32. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. SGMO currently holds a 9-day RSI of 64.32%, while 100-day RSI stands at 51.56%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. SGMO’s 9-day MACD is 0.49 and the company’s 100-day MACD stands at -0.37.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 21.57% by insiders and 68.85% by institutions. Regarding institutional holdings, Blackrock Inc. owns 7.34%, while the second top holder, Vanguard Group, Inc. (The), currently owns 6.01%.
Over the last six months, insiders have sold 35,000 with the most recent transaction from DILLY STEPHEN GEORGE, Director, with a sell at price 6.00 per share.
Overall, the recommended rating for SGMO is Moderate Buy. Currently, the company has 10 analysts watching the stock, and the average quarterly earnings estimate is -0.24. Quarterly revenue estimates are averaging 26.55M with the high estimate reaching 50.1M and the low at 15M.